{"id":{"repo_id":"birmingham","oai_identifier":"oai:etheses.bham.ac.uk:7109"},"canonical_url":"https://search.ndltd.org/etd/birmingham/oai:etheses.bham.ac.uk:7109","repository":{"repo_id":"birmingham","name":"University of Birmingham","base_url":"https://etheses.bham.ac.uk/cgi/oai2"},"display":{"title":"Steroidogenesis in steroid related cancers","abstract":"Prostate cancer growth is androgen dependent, but can bypass treatments inhibiting androgen production and continues to grow, probably utilising the adrenal alternative dihydrotestosterone (DHT) biosynthesis pathway. In contrast, the role of steroids in ovarian cancer is not clearly defined, although it is known that progesterone and oestrogens affect this cancer proliferation. The thesis aims were to investigate steroid relation with prostate and ovarian cancers as well as characterise three adrenocortical carcinoma cell (ACC) lines derived from H295 cell line. The steroidogenesis characterisation of three ACC cell line strains indicated that they have similar steroidogenic capability to the native adrenal cortex. Another ACC cell line, H295R1, was used to investigate whether CYP17A1, a key enzyme in androgen synthesis, inhibition was sufficient to cause a shift towards the alternative DHT biosynthesis pathway. Although knockdown was achieved and affected steroidogenesis, no shift towards the alternative pathway was demonstrated. The ovarian cancer cell lines, A2780, COV434, CaOv-3 and OAW42, showed steroidogenic capabilities suggesting that the tumours are probably transformed with steroidogenic capability. The results obtained indicate that the adrenal gland might have a role in prostate cancer resistance to treatment. They also demonstrate that ovarian cancer might be steroid-producing and/or dependent.","abstract_html":"Prostate cancer growth is androgen dependent, but can bypass treatments inhibiting androgen production and continues to grow, probably utilising the adrenal alternative dihydrotestosterone (DHT) biosynthesis pathway. In contrast, the role of steroids in ovarian cancer is not clearly defined, although it is known that progesterone and oestrogens affect this cancer proliferation. The thesis aims were to investigate steroid relation with prostate and ovarian cancers as well as characterise three adrenocortical carcinoma cell (ACC) lines derived from H295 cell line. The steroidogenesis characterisation of three ACC cell line strains indicated that they have similar steroidogenic capability to the native adrenal cortex. Another ACC cell line, H295R1, was used to investigate whether CYP17A1, a key enzyme in androgen synthesis, inhibition was sufficient to cause a shift towards the alternative DHT biosynthesis pathway. Although knockdown was achieved and affected steroidogenesis, no shift towards the alternative pathway was demonstrated. The ovarian cancer cell lines, A2780, COV434, CaOv-3 and OAW42, showed steroidogenic capabilities suggesting that the tumours are probably transformed with steroidogenic capability. The results obtained indicate that the adrenal gland might have a role in prostate cancer resistance to treatment. They also demonstrate that ovarian cancer might be steroid-producing and/or dependent.","abstract_has_math":false,"creators":["Turgeman, Orli"],"institution":"University of Birmingham","degree_name":"m_sc","degree_level":"m_sc","degree_discipline":null,"degree_department":null,"school":null,"contributors":[],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2016,"date_issued":"2016-12","date_published":"2016-12","updated_at":"2026-11-19T09:29:11Z","subjects":["RC0254 Neoplasms. Tumors. Oncology (including Cancer)"],"languages":["eng"],"rights":[],"rights_urls":[],"identifier_entries":[],"person_identifier_entries":[]},"links":{"outbound_url":null,"outbound_label":null,"outbound_source":null,"record_url":null,"record_label":null,"record_kind":null,"record_source":null,"download_url":"http://etheses.bham.ac.uk//id/eprint/7109/1/Turgeman17MScbyRes.pdf","download_label":"Download PDF","download_source":"dc:identifier.uri","access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://etheses.bham.ac.uk/cgi/oai2?verb=GetRecord&metadataPrefix=uketd_dc&identifier=oai%3Aetheses.bham.ac.uk%3A7109","prefix":"uketd_dc"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor.sponsor","label":"Sponsor","values":["other"]},{"key":"dc:creator","label":"Author","values":["Turgeman, Orli"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date","label":"Dc Date","values":["2016-12"]},{"key":"dc:date.issued","label":"Date","values":["2016-12"]},{"key":"dc:publisher.department","label":"Dc Publisher Department","values":["College of Medical & Dental Sciences","Institute of Metabolism and Systems Research"]},{"key":"dc:publisher.institution","label":"Dc Publisher Institution","values":["University of Birmingham"]},{"key":"dc:relation.isreferencedby","label":"Dc Relation Isreferencedby","values":["http://etheses.bham.ac.uk//id/eprint/7109/"]},{"key":"dc:type","label":"Dc Type","values":["Thesis"]},{"key":"dc:type.qualificationlevel","label":"Dc Type Qualificationlevel","values":["m_sc"]},{"key":"dc:type.qualificationname","label":"Dc Type Qualificationname","values":["m_sc"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["RC0254 Neoplasms. Tumors. Oncology (including Cancer)"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language.dcterms_iso639_2","label":"Language (ISO 639-2)","values":["eng"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier.uri","label":"Identifier URI","values":["http://etheses.bham.ac.uk//id/eprint/7109/1/Turgeman17MScbyRes.pdf","http://etheses.bham.ac.uk//id/eprint/7109/2/Decl_IS_Turgeman17MScbyRes.pdf"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["Prostate cancer growth is androgen dependent, but can bypass treatments inhibiting androgen production and continues to grow, probably utilising the adrenal alternative dihydrotestosterone (DHT) biosynthesis pathway. In contrast, the role of steroids in ovarian cancer is not clearly defined, although it is known that progesterone and oestrogens affect this cancer proliferation. The thesis aims were to investigate steroid relation with prostate and ovarian cancers as well as characterise three adrenocortical carcinoma cell (ACC) lines derived from H295 cell line. The steroidogenesis characterisation of three ACC cell line strains indicated that they have similar steroidogenic capability to the native adrenal cortex. Another ACC cell line, H295R1, was used to investigate whether CYP17A1, a key enzyme in androgen synthesis, inhibition was sufficient to cause a shift towards the alternative DHT biosynthesis pathway. Although knockdown was achieved and affected steroidogenesis, no shift towards the alternative pathway was demonstrated. The ovarian cancer cell lines, A2780, COV434, CaOv-3 and OAW42, showed steroidogenic capabilities suggesting that the tumours are probably transformed with steroidogenic capability. The results obtained indicate that the adrenal gland might have a role in prostate cancer resistance to treatment. They also demonstrate that ovarian cancer might be steroid-producing and/or dependent."]},{"key":"dc:format","label":"Dc Format","values":["application/pdf"]},{"key":"dcterms:accessrights","label":"Dcterms Accessrights","values":["public","staffonly"]},{"key":"dc:title","label":"Title","values":["Steroidogenesis in steroid related cancers"]}]}],"canonical_facts":{"dc:contributor.sponsor":["other"],"dc:creator":["Turgeman, Orli"],"dc:date":["2016-12"],"dc:date.issued":["2016-12"],"dc:description.abstract":["Prostate cancer growth is androgen dependent, but can bypass treatments inhibiting androgen production and continues to grow, probably utilising the adrenal alternative dihydrotestosterone (DHT) biosynthesis pathway. In contrast, the role of steroids in ovarian cancer is not clearly defined, although it is known that progesterone and oestrogens affect this cancer proliferation. The thesis aims were to investigate steroid relation with prostate and ovarian cancers as well as characterise three adrenocortical carcinoma cell (ACC) lines derived from H295 cell line. The steroidogenesis characterisation of three ACC cell line strains indicated that they have similar steroidogenic capability to the native adrenal cortex. Another ACC cell line, H295R1, was used to investigate whether CYP17A1, a key enzyme in androgen synthesis, inhibition was sufficient to cause a shift towards the alternative DHT biosynthesis pathway. Although knockdown was achieved and affected steroidogenesis, no shift towards the alternative pathway was demonstrated. The ovarian cancer cell lines, A2780, COV434, CaOv-3 and OAW42, showed steroidogenic capabilities suggesting that the tumours are probably transformed with steroidogenic capability. The results obtained indicate that the adrenal gland might have a role in prostate cancer resistance to treatment. They also demonstrate that ovarian cancer might be steroid-producing and/or dependent."],"dc:format":["application/pdf"],"dc:identifier.uri":["http://etheses.bham.ac.uk//id/eprint/7109/1/Turgeman17MScbyRes.pdf","http://etheses.bham.ac.uk//id/eprint/7109/2/Decl_IS_Turgeman17MScbyRes.pdf"],"dc:language.dcterms_iso639_2":["eng"],"dc:publisher.department":["College of Medical & Dental Sciences","Institute of Metabolism and Systems Research"],"dc:publisher.institution":["University of Birmingham"],"dc:relation.isreferencedby":["http://etheses.bham.ac.uk//id/eprint/7109/"],"dc:subject":["RC0254 Neoplasms. Tumors. Oncology (including Cancer)"],"dcterms:accessrights":["public","staffonly"],"dc:title":["Steroidogenesis in steroid related cancers"],"dc:type":["Thesis"],"dc:type.qualificationlevel":["m_sc"],"dc:type.qualificationname":["m_sc"]},"updated_at":"2026-11-19T09:29:11Z"}